1. Home
  2. XNCR vs EIM Comparison

XNCR vs EIM Comparison

Compare XNCR & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • EIM
  • Stock Information
  • Founded
  • XNCR 1997
  • EIM 2002
  • Country
  • XNCR United States
  • EIM United States
  • Employees
  • XNCR N/A
  • EIM N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • EIM Finance/Investors Services
  • Sector
  • XNCR Health Care
  • EIM Finance
  • Exchange
  • XNCR Nasdaq
  • EIM Nasdaq
  • Market Cap
  • XNCR 579.3M
  • EIM 543.0M
  • IPO Year
  • XNCR 2013
  • EIM N/A
  • Fundamental
  • Price
  • XNCR $9.65
  • EIM $9.59
  • Analyst Decision
  • XNCR Buy
  • EIM
  • Analyst Count
  • XNCR 8
  • EIM 0
  • Target Price
  • XNCR $29.29
  • EIM N/A
  • AVG Volume (30 Days)
  • XNCR 968.8K
  • EIM 215.2K
  • Earning Date
  • XNCR 08-04-2025
  • EIM 01-01-0001
  • Dividend Yield
  • XNCR N/A
  • EIM 4.32%
  • EPS Growth
  • XNCR N/A
  • EIM N/A
  • EPS
  • XNCR N/A
  • EIM N/A
  • Revenue
  • XNCR $127,228,000.00
  • EIM N/A
  • Revenue This Year
  • XNCR N/A
  • EIM N/A
  • Revenue Next Year
  • XNCR $29.35
  • EIM N/A
  • P/E Ratio
  • XNCR N/A
  • EIM N/A
  • Revenue Growth
  • XNCR N/A
  • EIM N/A
  • 52 Week Low
  • XNCR $7.16
  • EIM $8.61
  • 52 Week High
  • XNCR $27.24
  • EIM $10.51
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 59.62
  • EIM 43.73
  • Support Level
  • XNCR $8.76
  • EIM $9.50
  • Resistance Level
  • XNCR $9.60
  • EIM $9.63
  • Average True Range (ATR)
  • XNCR 0.52
  • EIM 0.09
  • MACD
  • XNCR 0.29
  • EIM -0.01
  • Stochastic Oscillator
  • XNCR 90.87
  • EIM 28.13

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About EIM Eaton Vance Municipal Bond

Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.

Share on Social Networks: